Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV

By sjmartinez • March 27, 2023

Kolossváry M, deFilippi C, McCallum S, Fitch KV, Diggs MR, Fulda ES, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Malvestutto CD, Currier JS, Casado JL, Gutiérrez F, Sereti I, Douglas PS, Zanni MV, Grinspoon SK. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. EBioMedicine. 2023 Mar 24;90:104538. doi: 10.1016/j.ebiom.2023.104538. Epub ahead of print. PMID: 36966617.

Tags: covid-19, Granzyme, human immunodeficiency virus, Infectious Diseases, Publications, SARS-CoV-2

Response to the Letter to the Editor on Laboratory Monitoring After Lentiviral Vector Exposure

Fujimoto GR, Wooley DP, Byers KB, Yang OO, Behrman AJ, Winters TH, Hudson TW. Response to the Letter to the Editor on Laboratory Monitoring After[...]

Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins[...]

Update on HIV Chemoprevention

Blair CS, Cambou MC, Landovitz RJ. Update on HIV Chemoprevention. Annu Rev Med. 2025 Jan;76(1):43-56. doi: 10.1146/annurev-med-042823-013707. PMID: 39869431.